The Cholangiocarcinoma market is characterised by continuous product approvals and launch of novel targeted therapies. Cholangiocarcinoma refers to a rare type of cancer that forms in the bile ducts. Symptoms include jaundice, abdominal pain and weight loss. Currently, surgery offers the best chance of cure if the cancer is diagnosed at an early stage, prior to spreading. However, recurrence is...
English
Arabic
Français
Español
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian